Cell Biology Quiz: Antibody Based Techniques
20 questions · exam conditions
0:00
Antibody Based TechniquesQuestion 1 of 20

A Western blot experiment uses a polyclonal primary antibody raised against full-length recombinant protein X. The blot shows the expected band at 60 kDa, but also shows an unexpected band at 40 kDa that disappears when cells are treated with a protease inhibitor cocktail. A monoclonal antibody against the N-terminus of protein X detects only the 60 kDa band, while a monoclonal antibody against the C-terminus detects both bands. What is the most likely identity of the 40 kDa band?

A cross-reactive protein that shares sequence homology with the C-terminal region of protein X
A proteolytic fragment of protein X that retains the C-terminus but has lost the N-terminal region
An alternatively spliced isoform of protein X that lacks the N-terminal exons but retains the C-terminus
A post-translationally modified form of protein X with altered electrophoretic mobility due to glycosylation changes
A degradation product formed during sample preparation that maintains epitopes from both termini of protein X
← Back to quizzes

Cell Biology Quiz

Cell Biology Quiz: Antibody Based Techniques

Practice Antibody Based Techniques in Cell Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Antibody Based Techniques, giving you a quick way to practice the rules, question types, and explanations that matter most for Cell Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A Western blot experiment uses a polyclonal primary antibody raised against full-length recombinant protein X. The blot shows the expected band at 60 kDa, but also shows an unexpected band at 40 kDa that disappears when cells are treated with a protease inhibitor cocktail. A monoclonal antibody against the N-terminus of protein X detects only the 60 kDa band, while a monoclonal antibody against the C-terminus detects both bands. What is the most likely identity of the 40 kDa band?

  1. A cross-reactive protein that shares sequence homology with the C-terminal region of protein X
  2. A proteolytic fragment of protein X that retains the C-terminus but has lost the N-terminal region (correct answer)
  3. An alternatively spliced isoform of protein X that lacks the N-terminal exons but retains the C-terminus
  4. A post-translationally modified form of protein X with altered electrophoretic mobility due to glycosylation changes
  5. A degradation product formed during sample preparation that maintains epitopes from both termini of protein X
Explanation: When analyzing Western blot results with multiple antibodies, you're essentially mapping where different epitopes exist on detected proteins. The key insight here is connecting the antibody specificity patterns with the protease inhibitor effect. The 40 kDa band disappears when protease inhibitors are added, immediately telling you it's created by proteolytic cleavage, not an inherent protein variant. The antibody detection pattern clinches the identification: the N-terminal antibody only sees the 60 kDa band (full-length protein), while the C-terminal antibody detects both the 60 kDa and 40 kDa bands. This means the 40 kDa fragment contains the C-terminus but lacks the N-terminus—exactly what you'd expect from a proteolytic fragment that lost its N-terminal region. Option A is wrong because a cross-reactive protein wouldn't disappear with protease inhibitors—it would be a stable, separate protein. Option C fails because alternative splicing creates variants during transcription, not protein fragments that disappear with protease inhibitors. Option D is incorrect because glycosylation changes typically cause smaller mobility shifts and wouldn't explain the specific antibody detection pattern or protease inhibitor sensitivity. Remember this pattern: when you see unexpected bands that disappear with protease inhibitors, think proteolytic fragments. Then use the antibody specificity data like a map—which parts of the original protein are still present in each band? This approach will help you distinguish between degradation products, splice variants, and post-translational modifications in future Western blot interpretations.

Question 2

An immunofluorescence protocol uses mouse anti-BrdU primary antibody to detect DNA synthesis in cells that were pulse-labeled with BrdU. The standard protocol includes DNA denaturation with 2M HCl treatment before antibody incubation. When a researcher omits the HCl treatment step, no BrdU signal is detected, even though the cells were confirmed to incorporate BrdU by an alternative detection method. However, other immunofluorescence antibodies work normally on cells processed without HCl treatment. What is the specific requirement for HCl treatment in BrdU detection?

  1. HCl treatment removes endogenous peroxidases that would interfere with the secondary antibody detection system used for BrdU staining
  2. The harsh acid treatment is necessary to permeabilize the nuclear envelope and allow antibody access to incorporated BrdU within the DNA
  3. HCl denatures the DNA double helix structure, exposing incorporated BrdU residues that are normally buried within the major groove (correct answer)
  4. Acid treatment neutralizes the negative charges on DNA phosphate groups that would otherwise repel the negatively charged antibody
  5. HCl treatment removes histone proteins that sterically block antibody access to BrdU incorporated within nucleosome core particles
Explanation: When you encounter BrdU immunofluorescence questions, focus on the structural accessibility of the antigen within DNA. BrdU (5-bromo-2'-deoxyuridine) is a thymidine analog that gets incorporated into newly synthesized DNA during S-phase, replacing thymine bases within the double helix structure. The key insight is that incorporated BrdU becomes buried within the major groove of double-stranded DNA, making it inaccessible to antibodies. HCl treatment denatures the DNA by disrupting hydrogen bonds between base pairs, unwinding the double helix and exposing the incorporated BrdU residues so antibodies can bind to them. This is why answer C is correct - acid denaturation is specifically required to reveal the hidden BrdU epitopes. Answer A is wrong because this isn't about peroxidase interference with detection systems, and the researcher confirmed other antibodies work fine without HCl. Answer B incorrectly suggests nuclear permeabilization is the issue, but other nuclear antigens are successfully detected without acid treatment, indicating the nuclear envelope isn't the barrier. Answer D misunderstands the problem - DNA charge isn't preventing antibody binding, and antibodies aren't negatively charged molecules that would be repelled by phosphate groups. The critical clue in the question is that BrdU incorporation was confirmed by alternative methods, proving the cells took up BrdU, yet immunofluorescence failed without HCl. This points specifically to an accessibility problem rather than incorporation, permeabilization, or charge issues. Remember: BrdU detection uniquely requires DNA denaturation because the antigen is structurally buried within intact double-stranded DNA.

Question 3

A researcher performs Western blot analysis using a primary antibody that recognizes both phosphorylated and non-phosphorylated forms of a signaling protein. The blot shows two bands: one at 45 kDa and another at 47 kDa. To determine which band represents the phosphorylated form, the researcher treats duplicate samples with lambda phosphatase before gel electrophoresis. After phosphatase treatment, only the 45 kDa band remains. What can be concluded about the relationship between phosphorylation and electrophoretic mobility?

  1. Phosphorylation increases the molecular weight and decreases electrophoretic mobility, causing the protein to migrate more slowly (correct answer)
  2. Phosphorylation decreases the molecular weight but increases negative charge, causing faster migration despite size changes
  3. Phosphorylation adds negative charges that increase electrophoretic mobility, causing the protein to migrate faster through the gel
  4. Phosphorylation causes conformational changes that reduce protein compactness, leading to slower migration through gel pores
  5. Phosphorylation has no effect on migration; the two bands represent different splice variants of the same protein
Explanation: When analyzing Western blot results involving protein phosphorylation, you need to understand how post-translational modifications affect both molecular weight and electrophoretic mobility. The key insight comes from the phosphatase treatment experiment: since only the 45 kDa band remains after lambda phosphatase removes phosphate groups, the 47 kDa band must represent the phosphorylated form. This tells us that phosphorylation increased the protein's apparent molecular weight from 45 kDa to 47 kDa. Each phosphate group adds about 80 Daltons, so multiple phosphorylation events can create measurable size differences. In SDS-PAGE, larger proteins migrate more slowly through the gel matrix, so the phosphorylated protein (47 kDa) moves slower than the unphosphorylated form (45 kDa). Answer A correctly identifies that phosphorylation increases molecular weight and decreases electrophoretic mobility. Answer B incorrectly suggests phosphorylation decreases molecular weight—the opposite of what we observe. Answer C misunderstands the dominant effect: while phosphorylation does add negative charges, the increased molecular weight outweighs any charge effects in SDS-PAGE, where proteins are already saturated with negative SDS detergent. Answer D focuses on conformational changes, but SDS denatures proteins into linear chains, so native structure isn't relevant to migration in this system. Remember this pattern: in SDS-PAGE Western blots, phosphorylated proteins typically appear as higher molecular weight bands that migrate more slowly. The phosphatase treatment experiment is a classic control to confirm which band represents the modified form.

Question 4

An immunofluorescence protocol calls for sequential incubation with mouse anti-protein A (1:500), rabbit anti-protein B (1:300), Alexa Fluor 488-conjugated anti-mouse IgG (1:1000), and Alexa Fluor 594-conjugated anti-rabbit IgG (1:1000). When cells are examined under the fluorescence microscope, both green and red signals appear in the same subcellular locations, even though proteins A and B are known to localize to different compartments. What modification would best resolve this issue?

  1. Increase the dilution of both primary antibodies to reduce non-specific binding and cross-reactivity between targets
  2. Use primary antibodies from the same species and distinguish them with different secondary antibody fluorophores
  3. Block with serum from both mouse and rabbit species before adding the primary antibodies to prevent cross-species interactions
  4. Perform the staining sequentially, completing the entire procedure for one protein before beginning the second protein staining
  5. Use secondary antibodies that have been cross-absorbed against the heterologous species to eliminate cross-reactivity (correct answer)
Explanation: When you encounter immunofluorescence troubleshooting questions, focus on the specific technical problem described and work backwards to identify what could cause overlapping signals when proteins should be in different locations. The issue here is likely antibody cross-reactivity - one or both primary antibodies are binding to unintended targets, creating false colocalization. Answer D resolves this by performing complete sequential staining: finish the entire procedure (primary antibody → secondary antibody → imaging/fixation) for protein A, then repeat the complete process for protein B. This prevents any interaction between the two staining protocols and ensures each antibody only detects its intended target. Answer A is incorrect because simply diluting primary antibodies won't eliminate cross-reactivity if the antibodies genuinely recognize multiple targets. Answer B makes the problem worse - using primary antibodies from the same species would create competition for the same secondary antibodies, making it impossible to distinguish the two proteins. Answer C misunderstands the problem; blocking with serum prevents non-specific binding to cellular components, not cross-reactivity between specific antibodies and their unintended protein targets. The key insight is recognizing that when two proteins with known different localizations appear colocalized, you're dealing with antibody specificity issues, not general background binding. Sequential complete procedures eliminate any possibility of antibody cross-talk. Study tip: In immunofluorescence troubleshooting questions, distinguish between non-specific binding (solved by blocking) and cross-reactivity between antibodies (solved by separation of protocols). Sequential staining is the gold standard when antibody specificity is questioned.

Question 5

In an immunofluorescence experiment, cells expressing a GFP-tagged protein are fixed and stained with an antibody against the same protein. When examined under the fluorescence microscope, the GFP signal (green) and antibody signal (red) show different subcellular localizations. The GFP signal appears primarily in the cytoplasm, while the antibody signal is predominantly nuclear. Both the tagged and untagged proteins have identical amino acid sequences except for the GFP tag. What is the most likely explanation for this discrepancy?

  1. The GFP tag is interfering with the nuclear localization signal, preventing proper nuclear import of the fusion protein (correct answer)
  2. The antibody is cross-reacting with a different nuclear protein that shares epitope similarity with the target protein
  3. The fixation process has caused the untagged protein to translocate from cytoplasm to nucleus artifactually
  4. The GFP fluorescence is being quenched in the nuclear environment, making nuclear GFP-tagged protein invisible
  5. The antibody is recognizing only the untagged endogenous protein, which localizes differently from the overexpressed tagged version
Explanation: When you encounter immunofluorescence questions involving protein localization discrepancies, think about what could cause a tagged protein to behave differently from its untagged counterpart. The key insight here is that protein trafficking depends on specific signal sequences that can be disrupted by modifications. Nuclear localization signals (NLS) are short sequences of basic amino acids that direct proteins to the nucleus via nuclear import machinery. These signals must be accessible and properly positioned to function. When you fuse a large tag like GFP (27 kDa) to a protein, you can sterically hinder or mask critical trafficking signals, even though the amino acid sequence remains technically identical. In this experiment, the GFP-tagged protein remains cytoplasmic because the bulky GFP tag is interfering with the NLS, preventing nuclear import machinery from recognizing or accessing the signal. Meanwhile, the antibody detects endogenous untagged protein that successfully localizes to the nucleus because its NLS remains unobstructed. Why the other answers fail: (B) Cross-reactivity would typically show broader, less specific staining patterns, not clean nuclear localization matching the expected protein location. (C) Fixation artifacts generally don't cause selective translocation of untagged versus tagged versions of the same protein. (D) Nuclear quenching of GFP is not a recognized phenomenon—GFP fluoresces equally well in nuclear and cytoplasmic environments. Study tip: Remember that protein tags, especially large ones like GFP, can interfere with normal protein function and localization. Always consider steric hindrance when interpreting tagged protein behavior that differs from expected patterns.

Question 6

A researcher performs a Western blot to detect a 50 kDa protein in cell lysates. After transfer, the membrane is blocked with 5% milk, incubated with primary antibody (1:1000 dilution), washed, incubated with HRP-conjugated secondary antibody, and developed with chemiluminescent substrate. The blot shows multiple bands at 50 kDa, 25 kDa, and 100 kDa. What is the most likely explanation for this banding pattern?

  1. The primary antibody is recognizing multiple epitopes on the same protein at different molecular weights
  2. The protein exists as monomers, dimers, and proteolytic fragments, all recognized by the same epitope-specific antibody (correct answer)
  3. Cross-contamination occurred during the transfer step, causing proteins to migrate to incorrect positions
  4. The secondary antibody is binding non-specifically to multiple endogenous proteins in the cell lysate
  5. The blocking step was insufficient, allowing the HRP-conjugated secondary to bind directly to the membrane
Explanation: When you encounter Western blot results with multiple bands at different molecular weights, think systematically about protein behavior and antibody specificity. The key insight is understanding what molecular weights can tell you about protein states. The correct answer is B because a single epitope-specific antibody can detect the same protein in different forms. The 50 kDa band represents the native monomer, the 25 kDa band indicates a proteolytic fragment (half the original size), and the 100 kDa band suggests a dimer (double the molecular weight). Since all three bands are detected by the same antibody, they must share the same epitope - meaning they're all related forms of the original protein. This pattern is common when proteins undergo partial degradation during sample preparation or naturally exist in multiple oligomeric states. Option A is incorrect because epitopes are specific amino acid sequences - the same epitope cannot exist at different molecular weights simultaneously. Option C misunderstands the transfer process; cross-contamination doesn't cause proteins to migrate to different positions since migration occurs during electrophoresis, before transfer. Option D is wrong because if the secondary antibody were binding non-specifically, you'd see many random bands throughout the blot, not just these three specific, mathematically-related molecular weights. For Western blot questions, always consider the mathematical relationships between band sizes. When you see bands that are multiples or fractions of each other (like 25, 50, and 100 kDa), think about protein complexes, dimers, and degradation products rather than technical artifacts or cross-reactivity.

Question 7

In an immunofluorescence experiment, cells are fixed with paraformaldehyde, permeabilized with Triton X-100, and stained with a primary antibody against a nuclear protein. The secondary antibody is conjugated to a fluorophore that excites at 495 nm and emits at 519 nm. When observed under the fluorescence microscope with appropriate filter sets, no signal is detected. However, the same protocol works successfully with a different primary antibody against a cytoplasmic protein. What is the most likely explanation for the lack of nuclear staining?

  1. The nuclear protein epitope is masked by cross-linking during paraformaldehyde fixation and requires antigen retrieval treatment (correct answer)
  2. The Triton X-100 permeabilization is insufficient to allow antibody access through the nuclear envelope pores
  3. The fluorophore is being quenched by the high DNA concentration within the nuclear compartment
  4. The primary antibody against the nuclear protein requires different fixation conditions that preserve nuclear morphology
  5. The nuclear protein has been extracted during the permeabilization step due to its high solubility in detergent
Explanation: When troubleshooting immunofluorescence experiments, you need to systematically consider each step of the protocol to identify where the process might be failing. Since the same protocol works with a cytoplasmic protein but fails with a nuclear protein, the issue is likely specific to how the nuclear antigen is being preserved or accessed. Paraformaldehyde fixation works by creating cross-links between proteins, which can sometimes mask or alter the three-dimensional structure of epitopes (the specific binding sites that antibodies recognize). Nuclear proteins are often particularly susceptible to this masking effect because they're frequently involved in protein-protein interactions and exist in complex chromatin structures. The correct answer is A - antigen retrieval treatment, typically involving heat and/or enzymatic treatment, can reverse some of this cross-linking and expose the masked epitopes. Let's examine why the other options don't explain the observation: B is incorrect because Triton X-100 effectively permeabilizes both the plasma membrane and nuclear envelope, allowing antibody access to nuclear compartments. C is wrong because DNA doesn't typically quench fluorophores at the concentrations found in nuclei, and if it did, you'd see reduced signal rather than complete absence. D is incorrect because if fixation conditions were the primary issue, you'd expect problems with nuclear morphology or general nuclear staining, not specific antibody binding failure. Remember this pattern: when one antibody works but another doesn't under identical conditions, suspect epitope-specific issues like masking due to cross-linking. Always consider antigen retrieval as a first troubleshooting step for nuclear proteins.

Question 8

A researcher performs immunoprecipitation followed by Western blot analysis to study protein-protein interactions. The immunoprecipitation uses an antibody against protein A, and the Western blot uses an antibody against protein B. The result shows that protein B co-immunoprecipitates with protein A. However, when the experiment is repeated using a different antibody against protein A (recognizing a different epitope), protein B is no longer detected in the immunoprecipitate. What is the most likely explanation for this result?

  1. The second antibody against protein A has lower affinity and cannot efficiently immunoprecipitate the protein complex
  2. The first antibody's epitope is located away from the interaction site, while the second antibody's epitope overlaps with the binding site for protein B (correct answer)
  3. Protein A exists in multiple conformational states, and only one antibody recognizes the conformation that binds protein B
  4. The interaction between proteins A and B is weak and can be disrupted by different washing conditions used with the second antibody
  5. The second antibody recognizes a different isoform of protein A that does not interact with protein B under these experimental conditions
Explanation: When analyzing immunoprecipitation results where different antibodies against the same target protein yield different outcomes, you need to consider how antibody binding sites might interfere with protein-protein interactions. The key insight here is steric hindrance. Protein A and protein B interact at a specific interface on protein A's surface. The first antibody recognizes an epitope located away from this interaction site, so when it binds to protein A, it doesn't disrupt the A-B complex. The antibody can successfully pull down protein A along with its binding partner, protein B. However, the second antibody recognizes an epitope that overlaps with or is very close to where protein B binds on protein A. When this antibody binds, it physically blocks protein B from associating with protein A, preventing co-immunoprecipitation. Option A is incorrect because if the second antibody simply had lower affinity, you would expect to see reduced but not completely absent protein B signal. Option C misinterprets the data - if conformational states were the issue, you'd expect this to be consistent across experiments rather than dependent on which antibody is used. Option D assumes the washing conditions changed between experiments, but the question states the only variable was the antibody used for immunoprecipitation. Remember this principle: when studying protein interactions through immunoprecipitation, always consider whether your detection antibody might interfere with the very interaction you're trying to observe. Choose antibodies that target epitopes distant from known or suspected binding interfaces.

Question 9

A Western blot experiment is performed to compare protein expression levels between two cell types. The primary antibody against the target protein works at a 1:2000 dilution, and the HRP-conjugated secondary antibody works at 1:5000 dilution. The chemiluminescent signal is strong for cell type A but barely detectable for cell type B. To determine whether this reflects true expression differences or technical issues, the researcher loads increasing amounts of cell type B lysate (10, 20, 40 μg total protein). The signal intensity increases proportionally with protein loading. What conclusion can be drawn?

  1. Cell type B has lower expression of the target protein, and the antibody detection system is working properly for both samples (correct answer)
  2. Cell type B contains a protease that degrades the target protein during sample preparation, reducing the detectable protein amount
  3. The antibody has different binding affinity for the target protein in the two cell types due to cell-specific post-translational modifications
  4. Cell type B expresses a different isoform of the target protein that has reduced antigenicity for the primary antibody used
  5. The transfer efficiency from gel to membrane was poor for cell type B samples due to differences in protein composition
Explanation: When analyzing Western blot results, you need to distinguish between technical problems and genuine biological differences in protein expression. The key experimental control here is the dose-response test with increasing protein amounts. The correct answer is A because the proportional increase in signal with increasing protein loading demonstrates that the detection system is functioning properly for cell type B. If the antibodies, detection reagents, or transfer conditions were problematic, you wouldn't see this linear relationship between input protein and signal intensity. Since the system responds predictably to more protein, the weaker initial signal simply reflects lower expression of the target protein in cell type B compared to cell type A. Option B is incorrect because protease degradation would likely produce a non-linear or plateau response as protein loading increases, since the proteases would also be concentrated and continue degrading the target protein. Option C fails because different antibody binding affinity due to post-translational modifications would still show the same proportional increase pattern, but the slope of the dose-response curve would be consistently different. Option D is wrong because if cell type B expressed a different isoform with reduced antigenicity, increasing the protein amount might not rescue the signal proportionally, or you might see additional bands at different molecular weights. Remember: in Western blots, a proper dose-response relationship with increasing sample loading is your best control for confirming that weak signals represent true expression differences rather than technical artifacts. Always include this control when comparing expression levels between samples.

Question 10

In a comparative immunofluorescence study, the same primary antibody against protein X is used on two different cell lines under identical conditions. In cell line 1, the protein shows distinct punctate cytoplasmic localization, while in cell line 2, it shows diffuse cytoplasmic distribution. Both cell lines express similar total levels of protein X as determined by Western blot analysis. RT-PCR confirms both cell lines express the same mRNA isoform of protein X. What is the most likely explanation for the different localization patterns?

  1. Cell line 1 and cell line 2 express different post-translationally modified forms of protein X that alter its subcellular targeting
  2. The two cell lines have different fixation sensitivities that affect protein X localization during the immunofluorescence procedure
  3. Cell line 1 expresses higher levels of a binding partner that sequesters protein X into specific subcellular compartments or complexes (correct answer)
  4. The primary antibody has different binding affinities for protein X in the two cell lines due to genetic background differences
  5. Cell line 2 has defective organelle biogenesis that prevents proper compartmentalization of protein X into its normal subcellular locations
Explanation: When you encounter immunofluorescence questions showing different protein localization patterns between cell lines, focus on what could cause the same protein to organize differently in space while maintaining identical expression levels and sequences. The key insight here is that protein localization depends heavily on cellular context—specifically, what other proteins are available to interact with your protein of interest. In cell line 1, the punctate (dot-like) pattern suggests protein X is being recruited into specific subcellular structures, organelles, or protein complexes. This typically occurs when binding partners or scaffolding proteins concentrate protein X at particular locations. Cell line 2's diffuse pattern indicates protein X remains freely distributed in the cytoplasm, likely because it lacks these organizing factors. Answer A is incorrect because both cell lines express the same mRNA isoform, and post-translational modifications affecting targeting would typically change total protein levels or create detectable size differences on Western blot. Answer B doesn't explain why identical fixation conditions would affect the same protein differently in different cell lines—fixation artifacts would be technique-dependent, not cell-type-dependent. Answer D is implausible because the same primary antibody is used under identical conditions, and genetic background differences wouldn't alter antibody-antigen binding significantly enough to create completely different localization patterns. For cell biology exams, remember that protein localization is rarely determined by the protein alone—it's usually about the cellular environment and what other proteins are present to interact with your target protein.

Question 11

During a co-immunoprecipitation experiment, protein A is immunoprecipitated using a specific antibody, and the immunoprecipitates are analyzed by Western blot for the presence of protein B. The result shows that protein B co-immunoprecipitates with protein A when cells are lysed in mild detergent (0.5% NP-40) but not when lysed in harsh detergent (1% SDS + 1% Triton X-100). Both lysis conditions effectively solubilize the proteins as confirmed by input controls. What can be concluded about the interaction between proteins A and B?

  1. Proteins A and B interact directly through high-affinity binding that is sensitive to ionic strength changes caused by different detergents
  2. The interaction between proteins A and B is mediated by lipid membranes that are disrupted by the harsh detergent conditions
  3. Proteins A and B are part of a larger protein complex that is disrupted by harsh detergent treatment, indicating indirect association (correct answer)
  4. Protein B binding to protein A requires proper protein folding that is maintained in mild but not harsh detergent conditions
  5. The harsh detergent conditions cause protein B to aggregate, making it unavailable for interaction with immunoprecipitated protein A
Explanation: Co-immunoprecipitation (co-IP) experiments reveal protein-protein interactions by testing whether proteins associate under different conditions. When interpreting co-IP results, pay close attention to how different lysis conditions affect the interaction—this tells you about the nature and strength of the protein association. The key insight here is that protein B co-precipitates with protein A under mild conditions (0.5% NP-40) but not under harsh conditions (1% SDS + 1% Triton X-100). Since both conditions effectively solubilize the proteins, the loss of co-precipitation isn't due to poor protein extraction. Instead, the harsh detergent disrupts the association between proteins A and B, suggesting they don't interact directly with each other. If they were directly bound with high affinity, you'd expect to see co-precipitation under both conditions. This pattern indicates that proteins A and B are part of a larger protein complex, and the harsh detergent breaks apart this complex while leaving the individual proteins intact. Answer C correctly identifies this indirect association. Answer A is incorrect because direct high-affinity interactions typically survive harsh detergent treatment. Answer B wrongly assumes the interaction is lipid-mediated, but both detergents would disrupt membrane associations. Answer D incorrectly suggests protein denaturation, but the input controls confirm both proteins remain solubilized and detectable. Remember: In co-IP experiments, compare results across different stringency conditions. Interactions that disappear under harsher conditions often indicate indirect associations through larger complexes rather than direct protein-protein binding.

Question 12

A Western blot experiment compares the expression of protein Z between control and treated cells. The membrane is probed with a primary antibody against protein Z, followed by an HRP-conjugated secondary antibody and chemiluminescent detection. The blot shows equal protein Z levels between control and treated samples. However, when the membrane is stripped and reprobed with an antibody against β-actin as a loading control, the treated sample shows 50% less β-actin signal than the control. What is the most appropriate interpretation of the protein Z results?

  1. The treatment has no effect on protein Z expression levels since the signals are equal between control and treated samples
  2. Protein Z expression is increased 2-fold by the treatment when corrected for the difference in protein loading between samples (correct answer)
  3. The result is inconclusive because β-actin is not a reliable loading control for this particular experimental treatment condition
  4. Protein Z expression is decreased by 50% in the treated sample, and the β-actin difference confirms this protein reduction
  5. The treatment specifically affects cytoskeletal proteins like β-actin but has no impact on other cellular proteins like protein Z
Explanation: When you encounter Western blot questions involving loading controls, you need to think about relative protein expression rather than absolute signal intensity. Loading controls like β-actin help ensure equal protein amounts were loaded in each lane, which is essential for accurate comparisons. Here's the key insight: if the treated sample shows 50% less β-actin, this means only half as much total protein was loaded compared to the control. Yet protein Z signals are equal between samples. This means the same amount of protein Z is present in half the total protein load, indicating protein Z expression has actually doubled in the treated cells. To calculate this: if treated cells loaded at 50% of control levels show equal protein Z signal, then protein Z concentration in treated cells is 2-fold higher (100%/50% = 2x). Answer A is wrong because it ignores the loading control difference entirely. You can't interpret Western blot results without accounting for loading variations. Answer C incorrectly suggests β-actin isn't reliable here - while treatments can sometimes affect housekeeping proteins, β-actin is generally stable and widely accepted as a loading control unless there's specific evidence suggesting otherwise. Answer D misinterprets the data by confusing total protein loading with target protein expression levels. Study tip: Always normalize Western blot results to loading controls. When signals appear equal but loading controls differ, calculate the fold-change by dividing target protein ratios by loading control ratios. This correction is crucial for accurate protein expression analysis.

Question 13

An immunofluorescence experiment uses a protocol that includes a 10-minute incubation with 0.3% hydrogen peroxide in methanol before the blocking step. When this step is omitted from the protocol, the cells show high background fluorescence throughout the cytoplasm, even in negative control samples that lack primary antibody. However, nuclear staining remains clean in both conditions. The experiment uses a biotinylated secondary antibody followed by streptavidin-HRP and tyramide signal amplification (TSA) with fluorescent tyramide. What is the purpose of the hydrogen peroxide treatment?

  1. To quench endogenous peroxidase activity that would otherwise cause non-specific activation of fluorescent tyramide throughout the cytoplasm (correct answer)
  2. To cross-link cellular proteins and improve their retention during the multiple washing steps required for TSA amplification protocols
  3. To permeabilize cellular membranes more effectively than standard detergent treatments for improved antibody penetration
  4. To remove endogenous biotin that could compete with biotinylated secondary antibody for streptavidin binding sites
  5. To reduce background autofluorescence from cellular components that interfere with tyramide fluorescence detection
Explanation: When you encounter immunofluorescence questions involving tyramide signal amplification (TSA), focus on the enzymatic amplification mechanism and potential sources of background signal. TSA uses horseradish peroxidase (HRP) to catalyze the deposition of fluorescent tyramide molecules. The key insight here is that many mammalian cells contain endogenous peroxidases, particularly in their cytoplasm. These native enzymes can also catalyze tyramide deposition, creating non-specific fluorescent signal even without your target antibody. The hydrogen peroxide treatment in methanol serves as a quenching step—it irreversibly inactivates these endogenous peroxidases by overwhelming them with substrate, preventing them from interfering with your specific signal. This explains why cytoplasmic background disappears with the treatment, while nuclear staining remains clean (nuclei have fewer endogenous peroxidases). Answer A correctly identifies this quenching mechanism. Answer B is incorrect because hydrogen peroxide doesn't cross-link proteins—formaldehyde or glutaraldehyde serve that function. Answer C is wrong since hydrogen peroxide isn't used for membrane permeabilization; detergents or alcohols handle that role. Answer D misses the mark because the problem isn't endogenous biotin competition—if that were the case, you'd see specific binding in unexpected locations, not diffuse cytoplasmic background. Remember: In TSA protocols, always consider endogenous enzyme activity as a source of background fluorescence. When you see diffuse cytoplasmic signal that disappears with peroxide treatment, think endogenous peroxidase quenching, not membrane permeabilization or biotin blocking.

Question 14

A researcher performs a Western blot using a rabbit polyclonal antibody against protein Y. The blot shows a single clean band at the expected molecular weight of 75 kDa. However, when the same antibody is used for immunofluorescence microscopy on the same cell type, no specific signal is detected above background levels. The immunofluorescence protocol includes standard fixation with 4% paraformaldehyde, permeabilization with 0.1% Triton X-100, and blocking with 10% goat serum. What is the most likely reason for the discrepancy between Western blot and immunofluorescence results?

  1. The antibody recognizes a conformational epitope that is preserved in Western blot conditions but destroyed by paraformaldehyde fixation
  2. The protein is present at levels too low for detection by immunofluorescence but sufficient for the more sensitive Western blot technique
  3. The 0.1% Triton X-100 concentration is insufficient for permeabilization, preventing antibody access to the intracellular protein
  4. The goat serum blocking step is interfering with the rabbit primary antibody binding through species-specific interactions
  5. The antibody recognizes a linear epitope that is accessible in denatured Western blot conditions but buried in the native protein structure (correct answer)
Explanation: When you encounter discrepancies between Western blot and immunofluorescence results with the same antibody, think about the fundamental differences between these techniques: Western blot uses denatured proteins under reducing conditions, while immunofluorescence preserves protein structure in fixed cells. The key insight here is understanding epitope types. Linear epitopes are continuous amino acid sequences that remain accessible even when proteins are denatured. Conformational epitopes depend on the protein's three-dimensional structure, requiring properly folded proteins with intact secondary and tertiary structures. In Western blot, proteins are denatured with SDS and heat, destroying conformational epitopes but preserving linear epitopes. Since this antibody works beautifully in Western blot, it must recognize a linear epitope. However, paraformaldehyde fixation creates cross-links between proteins that can mask or alter linear epitopes by chemically modifying amino acid residues (especially lysines) or by creating protein aggregates that bury the epitope. This makes the linear epitope inaccessible to the antibody during immunofluorescence, explaining why you see no signal despite the protein being present. Looking at the other options: (B) is unlikely since Western blot and immunofluorescence have similar sensitivity ranges. (C) doesn't fit because 0.1% Triton X-100 is a standard concentration that effectively permeabilizes most cell types. (D) is incorrect because goat serum actually enhances rabbit antibody performance by blocking non-specific binding sites. Study tip: Remember that fixation methods can dramatically affect epitope accessibility. When troubleshooting immunofluorescence, consider trying different fixatives (like methanol or acetone) or antigen retrieval methods if paraformaldehyde isn't working.

Question 15

A Western blot is performed using a mouse monoclonal primary antibody at 1:1500 dilution and an HRP-conjugated goat anti-mouse secondary antibody at 1:3000 dilution. The blot shows the expected band for the target protein, but also displays several high molecular weight bands (>150 kDa) that are not seen when using a different primary antibody against the same target protein. These high molecular weight bands disappear when the sample is treated with DTT (dithiothreitol) before electrophoresis. What is the most likely explanation for these additional bands?

  1. The mouse monoclonal antibody is detecting protein aggregates that are held together by disulfide bonds between cysteine residues
  2. The target protein forms covalent dimers and multimers through intermolecular disulfide bonds that are reduced by DTT treatment (correct answer)
  3. The sample contains reducing agents that interfere with SDS denaturation unless DTT is added to complete the reduction process
  4. The primary antibody is cross-linking multiple target proteins through its bivalent binding, creating artificial high molecular weight complexes
  5. Incomplete denaturation allows the target protein to remain associated with binding partners through disulfide-stabilized protein complexes
Explanation: When you encounter Western blot results showing unexpected high molecular weight bands that disappear with DTT treatment, think about protein structure and the role of disulfide bonds in maintaining protein complexes. The key clue here is that the additional bands disappear when DTT is added. DTT is a reducing agent that specifically breaks disulfide bonds (covalent bonds between cysteine residues). Since these high molecular weight bands (>150 kDa) are eliminated by DTT treatment, they must represent protein complexes held together by intermolecular disulfide bonds. The target protein is forming covalent dimers and multimers through disulfide linkages between separate protein molecules, which appear as larger molecular weight species on the gel. When DTT reduces these bonds, the complexes dissociate into individual protein monomers, leaving only the expected single band. Let's examine why the other options don't fit: (A) suggests general protein aggregates, but aggregates typically involve multiple types of non-covalent interactions, not just disulfide bonds that would be completely eliminated by DTT. (C) incorrectly implies that DTT helps SDS denaturation—actually, DTT specifically targets disulfide bonds, and SDS handles protein unfolding. (D) proposes antibody cross-linking, but antibodies don't create covalent bonds, and such interactions wouldn't be broken by a reducing agent. Remember this pattern: when you see unexpected high molecular weight bands on Western blots that disappear with reducing agents like DTT or β-mercaptoethanol, immediately consider intermolecular disulfide bond formation as the most likely explanation.

Question 16

An immunofluorescence experiment uses a primary antibody against tubulin and an Alexa Fluor 488-conjugated secondary antibody. When cells are examined under the fluorescence microscope, bright green fluorescence is observed throughout the cytoplasm rather than in the expected filamentous pattern. Controls include cells with no primary antibody (no fluorescence) and cells with primary antibody but no secondary antibody (no fluorescence). What is the most likely cause of the unexpected staining pattern?

  1. The primary antibody has lost its specificity due to improper storage and is binding to multiple cytoplasmic proteins
  2. The microtubule network has been disrupted by fixation conditions, causing tubulin to distribute throughout the cytoplasm (correct answer)
  3. The Alexa Fluor 488 dye has dissociated from the secondary antibody and is binding non-specifically to cellular components
  4. Cross-reactivity between the secondary antibody and endogenous immunoglobulins is causing widespread fluorescence signal
  5. The permeabilization step was too harsh, causing tubulin to leak out and redistribute within the fixed cell structure
Explanation: When troubleshooting immunofluorescence experiments, you need to systematically analyze both the staining pattern and the controls to identify what went wrong. The key insight here is that the controls worked perfectly (ruling out antibody binding issues), but the expected filamentous microtubule pattern is absent. The correct answer is B. Microtubules are dynamic structures that can be easily disrupted during cell fixation and processing. If fixation conditions were too harsh (wrong pH, temperature, or fixative concentration), the microtubule network would depolymerize, releasing tubulin subunits throughout the cytoplasm. The primary antibody would still bind specifically to tubulin, but now it's detecting dispersed tubulin monomers rather than organized filaments, creating diffuse cytoplasmic fluorescence. Let's examine why the other options don't fit: A is ruled out because your negative controls worked—if the primary antibody lacked specificity, you'd expect some background even without secondary antibody. C is incorrect because Alexa Fluor dyes are covalently linked to antibodies and don't dissociate under normal conditions. D doesn't match because endogenous immunoglobulins would create punctate, vesicular patterns (where antibodies are stored), not uniform cytoplasmic staining. Study tip: In immunofluorescence troubleshooting questions, always check if the controls make sense with each potential cause. When you see unexpected diffuse staining with good controls, think about whether the target protein's normal organization could have been disrupted during sample preparation—this is especially common with cytoskeletal proteins like tubulin, actin, and intermediate filaments.

Question 17

A monoclonal antibody was raised against a linear epitope consisting of amino acids 245-252 of protein X. When this antibody is used in Western blot analysis of cell lysates prepared under different conditions, it detects the protein in lysates prepared with SDS and β-mercaptoethanol, but fails to detect it in lysates prepared with SDS alone. What property of the epitope explains this observation?

  1. The epitope is located within a disulfide-bonded loop that becomes accessible only after reduction of cysteine residues (correct answer)
  2. The epitope contains hydrophobic residues that require β-mercaptoethanol as a solubilizing agent for antibody binding
  3. The epitope is normally buried within the protein core and becomes exposed only after complete protein denaturation
  4. The epitope spans two separate polypeptide chains that are held together by disulfide bonds between cysteine residues
  5. The epitope requires proper protein folding maintained by disulfide bonds to present the correct conformation for antibody recognition
Explanation: When you encounter Western blot questions involving different denaturing conditions, focus on how protein structure affects epitope accessibility. The key insight here is understanding what SDS and β-mercaptoethanol do differently to proteins. SDS is a detergent that disrupts non-covalent interactions (hydrogen bonds, ionic interactions, hydrophobic interactions) and denatures proteins, but it cannot break covalent disulfide bonds. β-mercaptoethanol is a reducing agent that specifically breaks disulfide bonds between cysteine residues. Since the antibody only works when both agents are present, the epitope must be hidden by disulfide bonding that SDS alone cannot disrupt. Answer A correctly identifies that the epitope lies within a disulfide-bonded loop. Without β-mercaptoethanol to reduce these bonds, the loop remains closed and the epitope stays buried, making it inaccessible to the antibody even though SDS has denatured the rest of the protein. Answer B incorrectly suggests hydrophobic solubility issues. β-mercaptoethanol isn't primarily a solubilizing agent for hydrophobic regions—that's SDS's role. Answer C is wrong because if the epitope were simply buried in the protein core, SDS denaturation alone would expose it. Answer D describes an inter-chain disulfide scenario, but the question specifies a linear epitope from amino acids 245-252, indicating a single continuous sequence within one chain. Remember: When Western blot detection depends on both SDS and reducing agents, think about disulfide bonds constraining epitope accessibility. The reducing agent is the critical clue pointing to cysteine-mediated structural constraints.

Question 18

A researcher performs immunoprecipitation using an antibody against protein M, followed by mass spectrometry analysis to identify interacting proteins. The results show that protein N co-immunoprecipitates with protein M. To confirm this interaction, the researcher performs the reciprocal experiment, immunoprecipitating protein N and probing for protein M by Western blot. However, protein M is not detected in the protein N immunoprecipitates, even though both proteins are abundantly expressed and the antibodies work well individually. What is the most likely explanation for this asymmetric result?

  1. The interaction between proteins M and N is directional, requiring protein M as the binding initiator and protein N as the acceptor
  2. The antibody against protein N binds to an epitope that overlaps with the interaction site for protein M, blocking the interaction
  3. Protein M exists in limiting amounts relative to protein N, making the M-N complex a small fraction of total protein N (correct answer)
  4. The antibody against protein N has lower immunoprecipitation efficiency, failing to capture sufficient protein N-containing complexes
  5. Protein N undergoes conformational changes upon antibody binding that destabilize its interaction with protein M during the immunoprecipitation
Explanation: When analyzing asymmetric immunoprecipitation results, you need to consider the stoichiometry and relative abundance of interacting proteins. This technique's success depends not just on whether proteins interact, but on how much of each protein exists in complex form versus free form. The key insight here is understanding what fraction of each protein pool is actually bound to its partner. When protein M is limiting relative to protein N, most protein M molecules will be bound to protein N (making co-immunoprecipitation of N with M successful), but only a small fraction of the abundant protein N will be complexed with the scarce protein M. This makes answer C correct – when you immunoprecipitate the abundant protein N, the small amount of associated protein M gets diluted below detection limits. Answer A incorrectly suggests directional binding, but protein interactions are typically bidirectional once formed. The asymmetry isn't about binding mechanics but about relative quantities. Answer B proposes epitope blocking, but this would prevent complex formation entirely, so you wouldn't see interaction in either direction. Answer D focuses on antibody efficiency differences, but the question states both antibodies work well individually, and this wouldn't explain why one direction works while the other fails completely. Remember this principle: in co-immunoprecipitation experiments, the limiting protein will usually co-precipitate efficiently with the abundant protein, but not vice versa. Always consider stoichiometry when interpreting asymmetric protein interaction results.

Question 19

An immunofluorescence protocol uses DAPI to stain nuclei (blue), phalloidin-TRITC to stain F-actin (red), and an antibody against α-tubulin followed by FITC-conjugated secondary antibody to stain microtubules (green). When the stained cells are examined, the expected blue nuclear staining and red actin filaments are clearly visible, but the green microtubule network appears as punctate dots rather than the expected filamentous pattern. The primary antibody concentration is 1:1000 and the secondary antibody is 1:500. What is the most likely cause of the altered microtubule staining pattern?

  1. The primary antibody concentration is too high, causing antibody aggregation that appears as punctate staining rather than filaments
  2. The FITC fluorophore has photobleached during the observation period, leaving only the brightest signal points visible
  3. The microtubule network has depolymerized during the fixation or staining procedure, leaving only centrosomal microtubule organizing centers (correct answer)
  4. Cross-talk between the TRITC and FITC fluorophores is causing interference that disrupts the microtubule signal pattern
  5. The secondary antibody is binding to endogenous immunoglobulins that are concentrated in specific cellular compartments
Explanation: When troubleshooting immunofluorescence experiments, you need to consider how each step—from fixation to imaging—can affect your final staining pattern. The key insight here is recognizing what punctate (dot-like) staining typically represents versus filamentous structures. The correct answer is C because punctate microtubule staining strongly suggests depolymerization of the microtubule network. Microtubules are dynamic structures that are sensitive to temperature changes, pH shifts, and chemical treatments during fixation and staining procedures. When they depolymerize, what remains visible are the microtubule organizing centers (MTOCs), primarily the centrosome, which appear as bright dots near the nucleus. This matches the observed punctate pattern perfectly. Let's examine why the other options don't fit: A) A 1:1000 primary antibody dilution is actually quite standard and relatively low—high concentrations typically cause background fluorescence rather than changing filaments to dots. B) FITC photobleaching would cause overall signal loss or fading, not a change from filamentous to punctate patterns. The signal would still maintain its original shape, just dimmer. D) TRITC/FITC cross-talk doesn't occur because their excitation and emission spectra are well-separated, and cross-talk typically causes bleed-through between channels rather than altered staining patterns. Study tip: When you see punctate staining instead of expected filamentous patterns in cytoskeletal immunofluorescence, always consider whether the target structure has been disrupted during sample preparation. Microtubules and microfilaments are particularly sensitive to fixation conditions, temperature, and buffer compositions.

Question 20

An immunofluorescence experiment uses a primary antibody against mitochondrial protein COX IV followed by a Cy3-labeled secondary antibody (red fluorescence). The cells also contain GFP-labeled peroxisomes (green fluorescence). When images are acquired, some regions show yellow fluorescence, suggesting colocalization between mitochondria and peroxisomes. However, when the same cells are treated with FCCP (a mitochondrial uncoupler that causes mitochondrial fragmentation) before fixation, the yellow regions disappear and only distinct red and green signals are observed. What is the most likely explanation for this observation?

  1. FCCP treatment causes COX IV protein to relocate from mitochondria to peroxisomes, eliminating the apparent colocalization
  2. The original yellow signal resulted from overlapping mitochondrial and peroxisomal structures that appear colocalized due to limited microscope resolution (correct answer)
  3. FCCP disrupts genuine metabolic interactions between mitochondria and peroxisomes that require mitochondrial membrane potential
  4. Mitochondrial fragmentation caused by FCCP increases the surface area-to-volume ratio, reducing the COX IV signal intensity below detection threshold
  5. FCCP treatment alters the spectral properties of the Cy3 fluorophore, preventing the appearance of yellow colocalization signals
Explanation: When you encounter immunofluorescence questions involving apparent colocalization, always consider whether you're seeing true molecular interaction or simply overlapping structures that appear merged due to microscope limitations. The key insight here is understanding resolution limits in fluorescence microscopy. Most standard fluorescence microscopes have lateral resolution limits of ~200-300 nanometers. Mitochondria and peroxisomes are often found in close proximity within cells, and when they're closer than this resolution limit, their fluorescent signals blend together, creating yellow fluorescence (red + green = yellow). This is optical overlap, not true colocalization of proteins. FCCP treatment fragments mitochondria into smaller pieces, physically separating them from nearby peroxisomes. Once separated beyond the resolution limit, you see distinct red (mitochondrial COX IV) and green (peroxisomal GFP) signals instead of merged yellow signals. This confirms that answer B is correct—the original yellow signal resulted from overlapping structures appearing colocalized due to limited microscope resolution. Answer A is wrong because COX IV doesn't relocate between organelles; it remains mitochondrial. Answer C incorrectly suggests genuine metabolic coupling, but true colocalization would involve the same proteins in both organelles, not separate organellar markers. Answer D is incorrect because FCCP fragmentation doesn't reduce COX IV expression levels or signal intensity below detection thresholds. Study tip: In colocalization experiments, always distinguish between optical overlap (structures too close to resolve separately) and true molecular colocalization (same protein in multiple locations). Physical separation treatments help differentiate between these possibilities.